Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.

Pediatric diabetes - 1 Mar 2018

Li Xiuzhen, Xu Aijing, Sheng Huiying, Ting Tzer Hwu, Mao Xiaojian, Huang Xinjiang, Jiang Minyan, Cheng Jing, Liu Li

Abstract excerpt

BACKGROUND: Sulfonylurea therapy can improve glycemic control and ameliorate neurodevelopmental outcomes in patients suffering from neonatal diabetes mellitus (NDM) with KCNJ11 or ABCC8 mutations. As genetic testing results are often delayed, it remains controversial whether sulfonylurea treatment should be attempted immediately at diagnosis or doctors should await genetic confirmation. OBJECTIVE: This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Disorders
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glyburide

Share to Hospitals, Pediatric

Share to Hypoglycemic Agents

Share to Infant, Newborn, Diseases

Share to Potassium Channels, Inwardly Rectifying

Share to Sulfonylurea Receptors

Source

Identifiers

PMID: 28791793
DOI: 10.1111/pedi.12560

Genes

ABCC8
KCNJ11
INS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.PMID 28791793Read ↗

Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.Semantic proximity Read ↗

Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes.Semantic proximity Read ↗

Permanent neonatal diabetes mellitus in China.Semantic proximity Read ↗

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.Semantic proximity Read ↗

Molecular and clinical characteristics of monogenic diabetes mellitus in southern Chinese children with onset before 3 years of age.Semantic proximity Read ↗

Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China.Semantic proximity Read ↗

ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?Semantic proximity Read ↗

Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up.Semantic proximity Read ↗

Case report: A 10-year prognosis of neonatal diabetes caused by a novel INS gene mutation.Semantic proximity Read ↗

Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old female with neonatal diabetes secondary to KCNJ11 gene mutation.Semantic proximity Read ↗

Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.Semantic proximity Read ↗

Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.